Independent register of U.S. FDA drug recalls · updated Oct 10, 2026
RxRecalls Get alerts

Is Oxaliplatin recalled?

Not under an active recall. Oxaliplatin was recalled 4 times in the past — all now closed. Most recent: Aug 29, 2019.

Most common reason: cGMP deviation (3 of these recalls)

Recalls are matched by product description. A recall usually affects specific lots, not every package of Oxaliplatin. “Active” means an FDA recall is still ongoing; “closed” means it was terminated or completed. Checked against openFDA on Oct 10, 2026.

Oxaliplatin recalls on record

none so far in 2026; 4 on record, newest first
Class II · Moderate risk

Eloxatin (OXALIplatin injection)

CGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.

Terminated cGMP deviation sanofi-aventis US, Inc. NDC 0024-0591-20 D-1408-2012
Class II · Moderate risk

Eloxatin (OXALIplatin injection)

CGMP Deviations: Eloxatin was manufactured by Ben Venue Laboratories, a contract manufacturer, which was recently inspected by the agency and revealed significant issues in Good Manufacturing Practices.

Terminated cGMP deviation sanofi-aventis US, Inc. NDC 0024-0590-10 D-1407-2012